Publications by authors named "Seitetsu Yoon"

Claim this Profile
L
Lymphocyte-Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis.
Tatsuya Sakane, Toshifumi Tada, Hiroshi Tei, Saeko Kushida, Kenji Momose, Seitetsu Yoon

Hepatol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Absolute Lymphocyte Counts and Lower Des-γ-Carboxyprothrombin Levels After Treatment Initiation Are Associated With the Clinical Efficacy of Tremelimumab Plus Durvalumab Combination Therapy for Hepatocellular Carcinoma.
Yuta Inoue, Yoshihiko Yano, Saeko Kushida, Seiya Hirohata, Seitetsu Yoon

JGH Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Presacral Neuroendocrine Tumor Presenting as Multiple Liver Metastasis: A Case Report.
Takafumi Watanabe, Seitetsu Yoon, Kohei Yamakawa, Toshiki Hyodo, Kenta Izaki

Am J Case Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
Yoshihiko Yano, Atsushi Yamamoto, Takuya Mimura, Saeko Kushida, Seiya Hirohata, Seitetsu Yoon

JGH Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of post-progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
Yoshihiko Yano, Atsushi Yamamoto, Akihiro Minami, Kenji Momose, Takuya Mimura, Seitetsu Yoon

JGH Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
Susumu Imoto, Soo Ryang Kim, Keisuke Amano, Etsuko Iio, Seitetsu Yoon

Dig Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective?
Yoshihiko Yano, Yasushi Seo, Hiroki Hayashi, Yuri Hatazawa, Hirotaka Hirano, Seitetsu Yoon

Biomed Rep· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.
Fugui Bai, Yoshihiko Yano, Soo-Ryang Kim, Yasushi Seo, Akira Miki, Seitetsu Yoon

Int J Mol Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C.
Yoshihiko Yano, Yasushi Seo, Akira Miki, Masaya Saito, Hirotaka Kato, Seitetsu Yoon

Int J Mol Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy.
Ahmed El-Shamy, Ikuo Shoji, Soo-Ryang Kim, Yoshihiro Ide, Susumu Imoto, Seitetsu Yoon

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the therapeutic effect using MD-CT immediately after RFA for HCC.
Toshiaki Ninomiya, Yasushi Seo, Yoshihiko Yano, Miyuki Nakaji, Kenichi Hamano, Seitetsu Yoon

Hepatogastroenterology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum hepatitis B virus DNA levels differentiating inactive carriers from patients with chronic hepatitis B.
Yasushi Seo, Seitetsu Yoon, Bui Xuan Truong, Hirotaka Kato, Kenichi Hamano

Eur J Gastroenterol Hepatol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay.
Yasushi Seo, Seitetsu Yoon, Kenichi Hamano, Miyuki Nakaji, Yoshihiko Yano

J Clin Gastroenterol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic pathway related to oval cell proliferation.
Yoshihiko Yano, Yoshitake Hayashi, Tadahisa Teramoto, Miyuki Nakaji, Peter Nagy, Seitetsu Yoon

J Gastroenterol Hepatol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases.
Yoshihiko Yano, Yoshitake Hayashi, Kimihiko Sano, Hidenobu Nagano, Miyuki Nakaji, Seitetsu Yoon

Cancer Lett· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat.
Miyuki Nakaji, Yoshihiko Yano, Toshiaki Ninomiya, Yasushi Seo, Kenichi Hamano, Seitetsu Yoon

Carcinogenesis· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response to interferon alpha treatment and long-term clinical outcome in Japanese patients with chronic HBV genotype C infection.
Yasushi Seo, Seitetsu Yoon, Kenichi Hamano, Miyuki Nakaji, Yoshihiko Yano

Int J Mol Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-3 (E-NPP3/CD203c/PD-I beta/B10/gp130RB13-6) in human colon carcinoma.
Yoshihiko Yano, Yoshitake Hayashi, Kimihiko Sano, Hiroshi Shinmaru, Yoshikazu Kuroda, Seitetsu Yoon

Int J Mol Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porphyria cutanea tarda with menopausal exacerbation: the possible role of menstruation as natural phlebotomy.
Eri Nishioka, Yoko Funasaka, Toshinori Bito, Akira Ito, Masahiro Tani, Seitetsu Yoon

J Am Acad Dermatol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of well-differentiated hepatocellular carcinoma arising in primary biliary cirrhosis.
Yoshihiko Yano, Seitetsu Yoon, Yasushi Seo, Toshiaki Ninomiya, Hidenobu Nagano

Kobe J Med Sci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein.
Satoshi Ogata, Ruth Huab Florese, Motoko Nagano-Fujii, Rachmat Hidajat, Lin Deng, Seitetsu Yoon

J Clin Microbiol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma.
Hidenobu Nagano, Tetsuya Noguchi, Kenjiro Inagaki, Seitetsu Yoon, Takashi Matozaki

Oncogene· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus DNA in anti-HBe-positive asymptomatic carriers.
Yasushi Seo, Seitetsu Yoon, Miyuki Nakaji, Yoshihiko Yano, Hidenobu Nagano

Intervirology· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma.
Yoshihiko Yano, Yoshitake Hayashi, Miyuki Nakaji, Hidenobu Nagano, Yasushi Seo, Seitetsu Yoon

Int J Mol Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma.
Satoshi Ogat, Yonson Ku, Seitetsu Yoon, Shigeru Makino, Motoko Nagano-Fujii

Microbiol Immunol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis